Табакокурение, электронные сигареты и щитовидная железа: риски развития тиреоидной патологии

Табакокурение — глобальная проблема здравоохранения уже многие годы. Особенно она усугубилась с момента массового производства табачных изделий. Давно не секрет, что табакокурение провоцирует различные заболевания, в том числе эндокринные, и способствует их прогрессированию. В настоящее время известно о роли генетической предрасположенности к развитию тиреоидной патологии и потенциальной роли различных средовых факторов в манифестации заболеваний щитовидной железы (ЩЖ). Наряду с потреблением йода, табакокурение — существенный фактор риска, влияющий на функциональное состояние и объем ЩЖ. С появлением электронных сигарет как альтернативы табачным изделиям возник закономерный вопрос: какое воздействие они оказывают на тиреоидный статус?

Настоящий литературный обзор обобщает современные представления о влиянии курения на ЩЖ, включая его взаимосвязь с изменением функции ЩЖ, развитием и прогрессированием заболеваний ЩЖ.

1. Who.int [Internet]. WORLD HEALTH ORGANIZATION: Health topics/Tobacco Available from: https://www.who.int/health-topics/tobacco#tab=tab_1

2. ПРОЕКТ Концепции осуществления государственной политики противодействия потреблению табака на 2017 - 2022 годы и дальнейшую перспективу. Доступно по: https://minzdrav.gov.ru/documents/9544. Ссылка активна на 29.01.24

3. Mucha L, Stephenson J, Morandi N, et al. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med. 2006;3(4):279-291. doi:10.1016/s1550-8579(06)80216-0

4. Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273-1285. doi:10.1056/NEJMoa2206916

5. Pan B, Jin X, Jun L, et al. The relationship between smoking and stroke: A meta-analysis. Medicine (Baltimore). 2019;98(12):e14872. doi:10.1097/MD.0000000000014872

6. Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7

7. Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155-164. doi:10.1002/ijc.23033

8. Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality--beyond established causes. N Engl J Med. 2015;372(7):631-640. doi:10.1056/NEJMsa1407211

9. Chang JT, Anic GM, Rostron BL, et al. Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2021;23(4):635-642. doi:10.1093/ntr/ntaa156

10. Paulis MG, Abbas MF, Abbas AH. Subchronic Effects of E-Cigarette and Conventional Tobacco Smoke Exposure on Pituitary and Thyroid Glands Functions: Comparative Experimental Study. Egypt J. Forensic Sci. Appli. Toxicol, Vol 15(2), December supp. 2015

11. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005;152(4):491-499. doi:10.1530/eje.1.01867

12. Babić Leko M, Gunjača I, Pleić N, Zemunik T. Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels. Int J Mol Sci. 2021;22(12):6521. Published 2021 Jun 17. doi:10.3390/ijms22126521

13. Kang J, Kong E, Choi J. Associations of Urinary Cotinine-Verified Active and Passive Smoking with Thyroid Function: Analysis of Population-Based Nationally Representative Data. Thyroid. 2018;28(5):583-592. doi:10.1089/thy.2017.0567

14. Asvold BO, Bjøro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007;167(13):1428-1432. doi:10.1001/archinte.167.13.1428

15. Utiger RD. Effects of smoking on thyroid function. Eur J Endocrinol. 1998;138(4):368-369. doi:10.1530/eje.0.1380368

16. Sawicka-Gutaj N, Gutaj P, Sowiński J, et al. Influence of cigarette smoking on thyroid gland--an update. Endokrynol Pol. 2014;65(1):54-62. doi:10.5603/EP.2014.0008.

17. Hegedüs L, Karstrup S, Veiergang D, et al. High frequency of goitre in cigarette smokers. Clin Endocrinol (Oxf). 1985;22(3):287-292. doi:10.1111/j.1365-2265.1985.tb03242.x

18. Petersen K, Lindstedt G, Lundberg PA, et al. Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med. 1991;229(5):407-413. doi:10.1111/j.1365-2796.1991.tb00367.x

19. Kim J, Song H, Lee J, et al. Smoking and passive smoking increases mortality through mediation effect of cadmium exposure in the United States. Sci Rep. 2023 Mar 8;13(1):3878. doi: 10.1038/s41598-023-30988-z.

20. Picciotto MR, Kenny PJ. Mechanisms of Nicotine Addiction. Cold Spring Harb Perspect Med. 2021;11(5):a039610. doi:10.1101/cshperspect.a039610

21. Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012;23(7):334-342. doi:10.1016/j.tem.2012.03.006

22. Vestergaard P. Smoking and thyroid disorders--a meta-analysis. Eur J Endocrinol. 2002;146(2):153-161. doi:10.1530/eje.0.1460153

23. Colzani R, Fang SL, Alex S, et al. The effect of nicotine on thyroid function in rats. Metabolism. 1998;47(2):154-157. doi:10.1016/s0026-0495(98)90212-8

24. Alzoubi KH, Aleisa AM, Gerges NZ, et al. Nicotine reverses adult-onset hypothyroidism-induced impairment of learning and memory: Behavioral and electrophysiological studies. J Neurosci Res. 2006;84(5):944-953. doi:10.1002/jnr.21014

25. Rehan M, Zargar UR, Sheikh IA, et al. Potential Disruption of Systemic Hormone Transport by Tobacco Alkaloids Using Computational Approaches. Toxics. 2022;10(12):727. Published 2022 Nov 26. doi:10.3390/toxics10120727

26. Fukayama H, Nasu M, Murakami S, Sugawara M. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh). 1992;127(6):520-525. doi:10.1530/acta.0.1270520

27. Serrano-Nascimento C, Nunes MT. Perchlorate, nitrate, and thiocyanate: Environmental relevant NIS-inhibitors pollutants and their impact on thyroid function and human health. Front Endocrinol (Lausanne). 2022;13:995503. Published 2022 Oct 21. doi:10.3389/fendo.2022.995503

28. Tonacchera M, Pinchera A, Dimida A, et al. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid (2004) 14(12):1012–9. doi: 10.1089/thy.2004.14.1012

29. Hayashi M, Futawaka K, Matsushita M, et al. Cigarette Smoke Extract Disrupts Transcriptional Activities Mediated by Thyroid Hormones and Its Receptors. Biol Pharm Bull. 2018;41(3):383-393. doi: 10.1248/bpb.b17-00735.

30. Gruppen EG, Kootstra-Ros J, Kobold AM, et al. Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study. Endocrine. 2020 Mar;67(3):613-622. doi: 10.1007/s12020-019-02125-2.

31. Jorde R, Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromsø study. Exp Clin Endocrinol Diabetes. 2006;114(7):343-347. doi:10.1055/s-2006-924264

32. Bartalena L, Bogazzi F, Tanda ML, et al. Cigarette smoking and the thyroid. Eur J Endocrinol. 1995;133(5):507-512. doi:10.1530/eje.0.1330507

33. Fukayama H, Nasu M, Murakami S, et al. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh). 1992;127(6):520-525. doi:10.1530/acta.0.1270520

34. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993:269:479-82. doi:10.1001/jama.269.4.479

35. Ericsson UB, Lindgärde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med. 1991;229(1):67-71. doi:10.1111/j.1365-2796.1991.tb00308.x

36. Wiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf). 2013 Aug;79(2):145-51. doi: 10.1111/cen.12222.

37. Antonelli A, Ferrari SM, Ragusa F, et al. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387. doi:10.1016/j.beem.2020.101387

38. Kurzynska A, Przybylik-Mazurek E, Węgrzynowicz K, et al. Wpływ wybranych czynników biologicznych oraz środowiskowych na przebieg i wystąpienie powikłań u pacjentów z chorobą Gravesa-Basedowa [Influence of selected endogenous and environmental factors on the course and complications of Grave's disease]. Przegl Lek. 2014;71(12):672-6. Polish. PMID: 25951694.

39. Shine B, Fells P, Edwards OM, et al. Association between Graves' ophthalmopathy and smoking. Lancet. 1990;335(8700):1261-1263. doi:10.1016/0140-6736(90)91315-2

40. Träisk F, Tallstedt L, Abraham-Nordling M, et al. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab. 2009;94(10):3700-3707. doi:10.1210/jc.2009-0747

41. Bartalena L, Piantanida E. Cigarette smoking: number one enemy for Graves ophthalmopathy. Pol Arch Med Wewn. 2016;126(10):725-726. doi:10.20452/pamw.3592

42. Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf). 1996;45(4):477-481. doi:10.1046/j.1365-2265.1996.8220832.x

43. Choi W, Li Y, Ji YS, et al. Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score. BMC Ophthalmol. 2018;18(1):303. Published 2018 Nov 21. doi:10.1186/s12886-018-0969-x

44. Cawood TJ, Moriarty P, O'Farrelly C, et al. Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link. J Clin Endocrinol Metab. 2007 Jan;92(1):59-64. doi: 10.1210/jc.2006-1824.

45. Francus T, Manzo G, Canki M, et al. Two peaks of interleukin 1 expression in human leukocytes cultured with tobacco glycoprotein. J Exp Med. 1989;170(1):327-332. doi:10.1084/jem.170.1.327

46. Hofbauer LC, Mühlberg T, König A, et al. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab. 1997;82(7):2244-2247. doi:10.1210/jcem.82.7.4068

47. Quadbeck B, Roggenbuck U, Janssen OE, et al. Impact of smoking on the course of Graves’ disease after withdrawal of antithyroid drugs. Exp Clin Endocrinol Diabetes. 2006; 114: 406–411. https://doi.org/10.1055/s-2006-924065

48. Plazinska MT, Sawicka-Gutaj N, Czarnywojtek A, et al. Radioiodine therapy and Graves' disease - Myths and reality. PLoS One. 2020;15(1):e0226495. Published 2020 Jan 13. doi:10.1371/journal.pone.0226495

49. Czarnywojtek A, Komar-Rychlicka K, Zgorzalewicz-Stachowiak M, et al. Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6 month follow up. Pol Arch Med Wewn. 2016;126(10):746-753. doi:10.20452/pamw.3505

50. Caulley L, Johnson-Obaseki S, Luo L, et al. Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Medicine (Baltimore). 2017 Feb;96(5):e5752. doi: 10.1097/MD.0000000000005752.

51. Belin RM, Astor BC, Powe NR, et al. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2004;89(12):6077-6086. doi:10.1210/jc.2004-0431

52. Kim SJ, Kim MJ, Yoon SG, et al. Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity. Sci Rep. 2019;9(1):4213. Published 2019 Mar 12. doi:10.1038/s41598-019-40708-1

53. Park S, Kim WG, Jeon MJ, et al. Serum thyroid-stimulating hormone levels and smoking status: Data from the Korean National Health and Nutrition Examination Survey VI. Clin Endocrinol (Oxf). 2018;88(6):969-976. doi:10.1111/cen.13606

54. Knudsen N, Bülow I, Laurberg P, Ovesen L, Perrild H, Jørgensen T. Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med. 2002;162(4):439-443. doi:10.1001/archinte.162.4.439

55. Волкова А.Р., Красильникова Е.И., Беркович О.А. и др. Функциональное состояние щитовидной железы, курение и кардиоваскулярный риск у больных ишемической болезнью сердца. Ученые записки СПбГМУ им. акад. И.П. Павлова. 2010; 17 (2): 17–21.

56. Lee JH, Chai YJ, Yi KH. Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis. Endocrinol Metab (Seoul). 2021. Jun;36(3):590-598. doi: 10.3803/EnM.2021.954.

57. Zhang L, Fang C, Liu L, et al. A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer. Environ Int. 2018;120:388-393. doi:10.1016/j.envint.2018.08.024

58. Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773-785. doi:10.1023/a:1026349702909

59. Negri E, Ron E, Franceschi S, et al. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control. 2002;13(4):365-372. doi:10.1023/a:1015263718760

60. Kabat GC, Kim MY, Wactawski-Wende J, Rohan TE. Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiol. 2012;36(4):335-340. doi:10.1016/j.canep.2012.03.013

61. Kitahara CM, Linet MS, Beane Freeman LE, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23(10):1615-1624. doi:10.1007/s10552-012-0039-2

62. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013 Mar 5;8(1):5. doi: 10.1186/1940-0640-8-5.

63. Rom O, Pecorelli A, Valacchi G, et al. Are E-cigarettes a safe and good alternative to cigarette smoking? Ann N Y Acad Sci. 2015 Mar;1340:65-74. doi: 10.1111/nyas.12609.

64. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014 May 13;129(19):1972-86. doi: 10.1161/CIRCULATIONAHA.114.007667. PMID: 24821826; PMCID: PMC4018182.

65. Valentine GW, Hefner K, Jatlow PI, et al. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity. J Dual Diagn. 2018;14(1):2-13. doi:10.1080/15504263.2017.1384877

66. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859

67. Who.int [Internet]. WORLD HEALTH ORGANIZATION: News/Urgent action needed to protect children and prevent the uptake of e-cigarettes. Available from: https://www.who.int/news/item/14-12-2023-urgent-action-needed-to-protect-children-and-prevent-the-uptake-of-e-cigarettes

68. Arastoo S, Haptonstall KP, Choroomi Y, et al. Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents. Am J Physiol Heart Circ Physiol. 2020;319(2):H262-H270. doi:10.1152/ajpheart.00192.2020

69. Андреева О.П., Терехов А.А. ЭЛЕКТРОННЫЕ СИГАРЕТЫ: АЛЬТЕРНАТИВА КУРЕНИЮ ИЛИ ВРЕД // Наука и образование. 2022. №2